X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.globenewswire.com//news-release/2023/10/25/2766493/0/en/Second-U-S-Patent-Issued-for-Safety-Shot-s-JW-700-Which-Boosts-Effectiveness-of-Minoxidil-Rogaine-in-1-5-Billion-Hair-Growth-Market.html
https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=11202310416
https://www.fiercepharma.com/marketing/hair-today-gone-tomorrow-minoxidil-drug-sellers-vir-health-numan-scalped-over-hair-loss
https://www.accesswire.com/712250/Jupiter-Wellness-Reports-Second-Quarter-2022-Financial-Results-and-Operational-Highlights
https://www.accesswire.com/706651/Jupiter-Wellness-Expands-Distribution-in-Asia-and-the-Middle-East-with-Newly-Acquired-Minoxidil-RogaineR-and-PhotociTM-Products
https://www.accesswire.com/705779/Jupiter-Wellness-Licenses-Minoxidil-Booster-to-Taisho
https://www.livemint.com/companies/news/dr-reddy-s-launches-drug-for-women-hair-loss-after-first-ever-approval-in-india-11631075606672.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-8-2020-1594182255.pdf
https://www.pharmacompass.com/pdf/news/masterpharm-llc-issues-voluntary-nationwide-recall-of-finasteride-plus-125mg-1589269968.pdf
https://www.fiercepharma.com/manufacturing/pl-developments-glad-to-get-nicotine-gum-lines-otc-deal-teva?utm_source=internal&utm_medium=rss
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209074
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209074
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209074
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208092
http://www.prnewswire.com/news-releases/perrigo-announces-first-to-market-launch-of-the-otc-store-brand-equivalent-to-womens-rogaine-foam-300420228.html
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208092
http://www.prnewswire.com/news-releases/pfenex-to-regain-full-rights-to-pf582-and-announces-phase-12-results-300310159.html
Market Place
Share 
